| [1] PubMed ID: | 33040438 |
| Disease Name: | Colonic Neoplasms |
| Sample: | colon cancer tissues |
| Dysfunction Pattern: | regulation[NF-κB/YY1 axis] |
| Validated Method: | RNA Pull-Down//Western Blot//qRT-PCR//RIP//Luciferase Report Assay//EdU Staining//ChIP |
| Description: | LINC01578 was upregulated in colon cancer, associated with metastasis, advanced clinical stages, poor overall survival, disease-specific survival, and disease-free survival. Collectively, this study demonstrated that LINC01578 promoted colon cancer metastasis via forming a positive feedback loop with NF-κB/YY1 and suggested that LINC01578 represents a potential prognostic biomarker and therapeutic target for colon cancer metastasis. |
| Causality: | Yes |
| Causal Description: | Gain-of-function and loss-of-function assays revealed that LINC01578 enhanced colon cancer cell viability and mobility in vitro and colon cancer liver metastasis in vivo. |
| Clinical-realted Application: | LINC01578 was upregulated in colon cancer, associated with metastasis, advanced clinical stages, poor overall survival, disease-specific survival, and disease-free survival. |
|